Sun Zhongjie
Department of Medicine, College of Medicine, University of Florida, Gainesville 32610-0274, USA.
Can J Cardiol. 2006 Mar 1;22(3):235-40. doi: 10.1016/s0828-282x(06)70903-5.
Molecular cardiology is a new and fast-growing area of cardiovascular medicine that aims to apply molecular biology techniques for the mechanistic investigation, diagnosis, prevention and treatment of cardiovascular disease. As an emerging discipline, it has changed conceptual thinking of cardiovascular development, disease etiology and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. With the rapid development and application of molecular biology techniques, scientists and clinicians are closer to curing heart diseases that were thought to be incurable 20 years ago. There clearly is a need for a more thorough understanding of the molecular mechanisms of cardiovascular diseases to promote the advancement of stem cell therapy and gene therapy for heart diseases. The present paper briefly reviews the state-of-the-art techniques in the following areas of molecular cardiology: gene analysis in the diseased heart; transgenic techniques in cardiac research; gene transfer and gene therapy for cardiovascular disease; and stem cell therapy for cardiovascular disease.
分子心脏病学是心血管医学中一个新兴且快速发展的领域,旨在应用分子生物学技术对心血管疾病进行机制研究、诊断、预防和治疗。作为一门新兴学科,它改变了人们对心血管发育、疾病病因和病理生理学的概念性认识。尽管分子心脏病学仍处于非常早期的阶段,但它为理解和控制心血管疾病开辟了一条充满希望的途径。随着分子生物学技术的迅速发展和应用,科学家和临床医生距离治愈20年前被认为无法治愈的心脏病更近了一步。显然,需要更深入地了解心血管疾病的分子机制,以推动心脏病干细胞治疗和基因治疗的进展。本文简要综述了分子心脏病学以下领域的最新技术:患病心脏的基因分析;心脏研究中的转基因技术;心血管疾病的基因转移和基因治疗;以及心血管疾病的干细胞治疗。